Aurobindo Pharma subsidiary’s plant in Andhra Pradesh issued five observations by U.S. FDA
The U.S.Food and Drug Administration has issued five observations to Aurobindo Pharma subsidiary APL Healthcare’s unit in Andhra Pradesh. The U.S.FDA inspected Unit-IV of APL Healthcare in SPSR Nellore District,…
Aurobindo Pharma clarifies, reports of Zentiva buyout ‘premature’, no binding agreement yet
Aurobindo Pharma, a leading player in the active pharmaceutical ingredient and generic market, has issued a statement clarifying that reports of buying out Prague-based generic drugmaker Zentiva are ‘premature’, and…
Aurobindo to Start US Units This Year; China Plant Nears Q3 FY26 Break-Even
New Delhi, August 18, 2025 — Aurobindo Pharma said two manufacturing units in the United States are slated to start production within the current fiscal, tightening the company’s supply chain…
Aurobindo Pharma to manufacture, supply long acting HIV treatment drug
Aurobindo Pharma on Tuesday said it will manufacture and supply the long-acting injectable HIV treatment cabotegravir across 133 countries. The Hyderabad-based drugmaker has been selected as one of the generic…
Aurobindo Pharma arm gets marketing authorization in UK for Dyrupeg
Hyderabad: Aurobindo Pharma Ltd wholly owned step-down subsidiary CuraTeQ Biologics has obtained marketing authorization from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for Dyrupeg, its pegylated filgrastim biosimilar…
I-Sec downgrades Aurobindo Pharma to Add, target price Rs 1,330
ICICI Securities has downgraded Aurobindo Pharma to Add (from Buy earlier) with a revised target price of Rs 1,330 (earlier Rs 1,445). The current market price of Aurobindo Pharma Ltd.…
Fire breaks out at Hyderabad-based Aurobindo Pharma’s plant
New Delhi: Aurobindo Pharma on Monday said a fire incident occurred at the Andhra Pradesh-based plant of its subsidiary Lyfius Pharma on April 27, leading to temporary suspension of operations.…
Pharma Stocks Plunge on Trump Tariff Threat
New Delhi: Shares of Pharmaceutical companies on Friday tumbled up to 10 per cent amid reports that the Trump Administration will soon announce tariffs on pharma imports and emphasised that…
Aurobindo Pharma arm’s New Jersey warehouse gets OAI status after U.S. FDA inspection
The U.S. Food and Drug Administration (U.S. FDA) has classified a warehouse of Aurobindo Pharma subsidiary in New Jersey, U.S. as Official Action Indicated (OAI) after an inspection it conducted.…
Aurobindo Pharma shares jump 2% after UK arm secures regulatory approval for cancer drug
Aurobindo Pharma shares jumped 2% to an intraday high of Rs 1,265 on the BSE after its wholly owned step-down subsidiary CuraTeQ Biologics received approval from the UK‘s Medicines and Healthcare products Regulatory Agency…
